Alzheimer's disease generally referred as a type of neurological disorder is characterized by difficulty in remembering things (Tanzi, 2012). This is also known as short term memory loss accompanied by severe cases of dementia. It can broadly be defined as a neuro-generative disorder in which the nerves and tissues associated with the central nervous systems start degenerating with time (Mayeux and Stern, 2012). This disease is generally noticed in old age citizens. The neurological disorder is also characterized by disorientation, behavioral changes, loss of confidence and motivation and finally death of th
1.1 Physiological origin of Alzheimer’s
Genetics have been considered as the origin of Alzheimer's because based on many researchers and studies it has been reported that this is an autosomal dominant disorder that is caused due to mutations attributed in three types of genes in the body (Zlokovic, 2013). Environmental changes also increases the risk of this disease to a higher extent, Greek researchers and philosophers reported that this generative disorder is increased or progressed due to the increasing age. 56% of old age individuals are likely to suffer from dementia or Alzheimer's at early or alter stages of life.
1.2 Signs and symptoms of Alzheimer’s
Dementia has been widely classified into various stages depending upon the signs and symptoms exhibited by an individual. Pre-dementia is a case in which neurological testing system can reveal the presence of cognitive disabilities associated with Alzheimer's (Porsteinsson and et.al, 2014). The most common symptoms of this disorder is that a person tends to forget everyday activities which he/she performs daily. They suffer from severe mood swings which is accompanied by abrupt behavioural changes and unusual attitude. They report difficulty in remembering everything which has recently occurred in their life. They also face problem in learning different things due to early progression of the disease. (Mayeux and Stern, 2012). They also turn their behaviour in abusive and anxious which also results in depression, anxiety and mental trauma.
1.3 Contributory factors to the onset of Alzheimer's
There are many contributing factors that increases the risk of Alzheimer's ion later stages of life. These factors are discussed below.
Age: With increasing age the risk of developing Alzheimer's increases. At the age of 65 the disease starts progressing at a very high intensity (De Felice and Ferreira, 2014).
Gender: According to the survey it has been reported that women are more likely to cause Alzheimer's then men.
Family history: If Alzheimer's is present in history then the members of the same family are likely to encounter the same disease at later stages of life.
Genetic Disorder: During pregnancy, if a child is diagnosed with down syndrome genetic disorder then there are more chances that he/she will suffer from Alzheimer's in later stages of life (Sankaranarayanan and et.al, 2013).
2.1 Process of referral to identified specialist services in Alzheimer's
Generally, referrals in the case of Alzheimer's are identified when a GP is not able to handle the patient without the support of a specialist (Komurcu and et.al, 2016). It usually involves the transfer of responsibility from one GP to another health professional so that they are treated effectively. Referrals are made so that proper diagnosis and treatment are provided to all the patients who are suffering from a degenerative neurological disorder.
2.2 Investigative processes and procedures involved in assessing
Alzheimer's is usually investigated by reviewing the medical history of the patient. A various physical test can be applied in order to study the neurology associated with the disease (Cohen and et.al, 2013). Advancement in magnetic resonance imaging, computed tomography and single proton emission tomography can be used so that the physicians can have a detailed idea about the cerebral pathology and stages of Alzheimer's that has been affected patient's central nervous system. There is one more method known as assessment of intellectual functioning which helps in determining the memory reattainment of an individual (Ju and et.al,2013).
3.1 Compare and contrast care services available in relation to Alzheimer's
There are variety of care services that is available for patients suffering from Alzheimer's. All the service users should be given independence and mobility so that can be physically active and mobile throughout the day (Petersen and et.al, 2013). Carers who are associated with specific individuals should also provide them with physical support and care so that they are able to perform various activities.
3.2 Roles and responsibilities of the professionals in relation to Alzheimer's
The main role and responsibility of health and social care professionals is to provide appropriate information and advice, support and care to all the patients who are suffering from Alzheimer's (Lock, 2013). If a person is not behaving in proper manner and is constantly forgetting different things then it is the duty of GP or physician to make verbal or telephonic conversation with the individuals. People who are appointed as community nurses should ensure that effective primary care services is provided to all the patients. With the advancement in dementia or Alzheimer's stage the care and support given to all the service users should be satisfactory (How health and social care professionals can help, 2016).
3.3 Ranges of treatment available for patients with Alzheimer's
Different range of treatments have been identified by the physicians and researcher in order to successfully treat individuals suffering from Alzheimer's. Medications, clinical interventions, care services and feeding tubes are some treatments available for Alzheimer's (Tanzi, 2012). Drugs such as rivastigmine, donepazil, acetylcholinesterase inhibitors are some medications that are prescribed to these patients. Psychosocial interventions involve emotional and behavioral cognition therapies which can help in supporting to a great extent (Mayeux and Stern, 2012).
3.4 Monitoring processes involved for Alzheimer's
Generally, there are two types of process which can help in monitoring Alzheimer's. The initial one is baseline assessment and the second option is the ongoing evaluation on the basis of diagnosis of Alzheimer's (Zlokovic, 2013). When the patient initially visits for diagnosis and evaluation then it is the duty of physician to maintain a mini mental state examination statement so that they are able to primarily focus on cognition and functional disability associated with the patient. The ongoing evaluation should be continued by the patient as per the direction of physicians so that gradual positive changes are noticed in health of the individual (Porsteinsson and et.al, 2014).
4.1 Extent to which an individual diagnosed with Alzheimer's would need to adapt his/her lifestyle
It is very important to bring about considerable changes in the overall lifestyle of an individual so that the impact of disease do not affect the mental state of a person to a greater extent (De Felice and Ferreira, 2014). According to the cognitive return theory the neural functioning can be gradually increased by engaging in positive brain activities such as playing music, brain puzzles, social gathering and interactions and education.
4.2 Range of strategies that would help individuals cope with Alzheimer's
Developing daily routine will help a patient in providing care services in an effective manner (Sankaranarayanan and et.al, 2013). In majority of the cases it is noticed that a person is not able to tie their shoes or place clothes in a hamper but providing them care and support will help them in practising their daily activities on independent basis. They should also be allowed to join various social and help group so that social interactions is increased
4.3 Prognosis and potential long term outcomes for the individual for Alzheimer's
It is very difficult to diagnose Alzheimer's at the initial stages because the progression of these diseases is not enhanced during the starting years of life (Komurcu and et.al, 2016). The symptoms can be diagnosed with mild cognitive impairment to memory loss which increases at later stages of life. The life expectancy of a person is reduced due to the occurrence of Alzheimer's as this neurological disorder increases the degeneration as soon as a person grows older (Petersen and et.al, 2013).
The overall report was based in diagnosis and management required in handling patients suffering from Alzheimer's. Physiological characteristics were discussed in the report which were accompanied by range of treatments, investigative procedures and interventions. Lastly the study also included prognosis and long term outcomes of Alzheimer's.
- Cohen, R.M. and et.al., 2013. A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss. The Journal of neuroscience.
- De Felice, F.G. and Ferreira, S.T., 2014. Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes.
- Ju, Y.E.S. and et.al., 2013. Sleep quality and preclinical Alzheimer disease. JAMA neurology.
- Komurcu, H.F. and et.al., 2016. Plasma levels of vitamin B12, epidermal growth factor and tumor necrosis factor alpha in patients with alzheimer dementia. International Journal of Research in Medical Sciences.
- Lock, M., 2013. The Alzheimer conundrum: Entanglements of dementia and aging. Princeton University Press.
- Mayeux, R. and Stern, Y., 2012. Epidemiology of Alzheimer disease. Cold Spring Harbor perspectives in medicine.
- Petersen, R.C. and et.al., 2013. Mild cognitive impairment due to Alzheimer disease in the community.Annals of neurology.
- Porsteinsson, A.P. and et.al., 2014. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. Jama.
- Sankaranarayanan, R. and et.al., 2013. Assessing the French Alzheimer plan. Nat Genet.